Ketan Dhatariya | Professor Ketan Dhatariya

Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare professional-delivered diabetes prevention program: the Norfolk Diabetes Prevention Study (NDPS).

by Ketan Dhatariya | Oct 3, 2019 | 2019, Original Articles

Garner NJ, Pascale M, France K NDPS Group, On behalf of NDPS Group. BMJ Open Diabetes Research and Care...

A Randomized, Multiple-Dose Study of Subcutaneous UTTR1147A (IL-22Fc) in Patients with Neuropathic, Non-Healing Diabetic Foot Ulcers (DFUs).

by Ketan Dhatariya | Sep 30, 2019 | 2019, Abstracts

Piaggesi A, Wong C, Game F, Baruch A, Whitelaw D, Rayman G, Rothenberg ME, Wang Y, Anderson CJ, Dash A, Li C, Pollak R, Dheerendra S, Mannucci E, Dhatariya K, Vas P, Flanagan W, Lázaro-Martínez JL, Arora PS. DFCon –...

Patients with Giant Cell Arteritis have a lower HbA1c compared to controls.

by Ketan Dhatariya | Sep 30, 2019 | 2019, Abstracts

Mukhtyar C, Dale M, Jones C, Dhatariya K. British Society for Rheumatology...

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019).

by Ketan Dhatariya | Sep 27, 2019 | Reviews

Dashora U, Patel DC, Gregory R, Winocour P, Dhatariya K, Nagi D. British Journal of Diabetes...

Diabetic ketoacidosis and hyperosmolar crisis in adults.

by Ketan Dhatariya | Sep 27, 2019 | Book Chapters

Dhatariya K. Medicine 2019;47...

« Older Entries

Next Entries »

PROFESSOR KETAN DHATARIYA

Consultant in Diabetes, Endocrinology & General Medicine

Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare professional-delivered diabetes prevention program: the Norfolk Diabetes Prevention Study (NDPS).

A Randomized, Multiple-Dose Study of Subcutaneous UTTR1147A (IL-22Fc) in Patients with Neuropathic, Non-Healing Diabetic Foot Ulcers (DFUs).

Patients with Giant Cell Arteritis have a lower HbA1c compared to controls.

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019).

Diabetic ketoacidosis and hyperosmolar crisis in adults.

Recent Posts